Growth factor receptor-mediated signal transduction and PI3K–AKT activation have been implicated in conferring resistance to conventional chemotherapy in breast cancer cells (Yu et al, 1996; Knuefermann et al, 2003). The gene discussed is PIK3CA; the disease is breast carcinoma.